Cargando…
AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate
COVID-19 is a novel disease caused by SARS-CoV-2 which has conquered the world rapidly resulting in a pandemic that massively impacts our health, social activities, and economy. It is likely that vaccination is the only way to form “herd immunity” and restore the world to normal. Here we developed a...
Autores principales: | Liu, Xuelan, Chang, Xinyue, Rothen, Dominik, Derveni, Mariliza, Krenger, Pascal, Roongta, Salony, Wright, Edward, Vogel, Monique, Tars, Kaspars, Mohsen, Mona O., Bachmann, Martin F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073683/ https://www.ncbi.nlm.nih.gov/pubmed/33921677 http://dx.doi.org/10.3390/vaccines9040403 |
Ejemplares similares
-
Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
por: Mohsen, Mona O., et al.
Publicado: (2018) -
TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle Immunization
por: Chang, Xinyue, et al.
Publicado: (2022) -
Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface
por: Wang, Dongliang, et al.
Publicado: (2018) -
The Adoption of Viral Capsid-Derived Virus-Like Particles (VLPs) for Disease Prevention and Treatments
por: Bogani, Giorgio, et al.
Publicado: (2020) -
CuMV VLPs Containing the RBM from SARS-CoV-2 Spike Protein Drive Dendritic Cell Activation and Th1 Polarization
por: Sebastião, Ana Isabel, et al.
Publicado: (2023)